Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1 - Concepedia

Concepedia

Publication | Open Access

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

DOI Full Paper Access

48

Citations

22

References

2003

Year

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt, Vincent P. Rocco, Patrick Spinazze, Daniel J. Koch, David L. Nelson, David B. Wainscott, Laura Ahmad, Janice Shaw,

Bioorganic & Medicinal Chemistry Letters

New AntidepressantsPsychoactive DrugPsychiatryFunctional SelectivityMedicinePsychotropic MedicationPsychopharmacologyDepressionNeuropharmacologyPharmacological AgentPharmacotherapyMood DisordersBiological PsychiatryPharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1